<DOC>
	<DOCNO>NCT00224016</DOCNO>
	<brief_summary>This study evaluate safety effectiveness anticholinergic drug treatment administer transdermal patch treat overactive bladder child neurological condition ( e.g . spina bifida ) contribute overactive bladder .</brief_summary>
	<brief_title>Safety Efficacy Study Transdermal Oxybutynin Treat Overactive Bladder With Neurological Condition</brief_title>
	<detailed_description>This study use multicenter , randomize , open-label , active-controlled , dose-titration , parallel group design , approximately pediatric patient detrusor overactivity associate neurological condition .</detailed_description>
	<mesh_term>Reflex , Abnormal</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Pediatric patient diagnosis detrusor overactivity associate neurological condition ; Use clean intermittent catheterization On stable dose oral oxybutynin participation Have one treatable condition , neurogenic bladder dysfunction , may cause urinary incontinence urgency Have medical condition precludes participation study may confound outcome study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>